Home » Blog » Lab Story – Prof Chris Molloy

Lab Story – Prof Chris Molloy

Lighthouse Labs

Prof Chris Molloy is CEO at Medicines Discovery Catapult. He talks about leading the UK Lighthouse Lab Network.

Related Blogs

Biomarkers

Unleashing the Potential of Human T...

Dr Michael Eyres, Lead Scientist at MDC, has been working on applying MDCs biomarkers expertise to a novel approach in drug discovery.

July 2024

Views from the Discovery Nation

Access to Labs

With availability limited and lab facilities not evenly spread across the UK, it is important to make well-informed decisions on the kind of lab space you need early on, because these choices can have consequences further down the line.

By Gareth Hampton

24 July 2024

Funding

Options for Commercialisation

Clare Terlouw, Head of LifeArc Ventures, LifeArc

10 July 2024

Uncategorised

IP Protection Strategy: The Univers...

Dr Geraint Lewis, Head of Enterprise Services, Newcastle University

11 July 2024

Uncategorised

Accessing the Skills for Successful...

Graeme Wilkinson, Head of Virtual R&D, MDC

3 July 2024

Funding

The Importance of Being Pitch-Ready...

Michael Salako, Investment Director, Start Codon

28 June 2024

Partnership

How do I Find the Right CRO for my ...

Dr Mike Piper Chief Commercial Officer and Dr Angelo Pugliese, Head of In-silico Discovery, BioAscent

28 June 2024

Intellectual Property

Cost-effective IP Strategies: Spott...

Dr Catrina Carroll, Strategy Leader, Collaborative R&D and Licensing, MDC

13 June 2024

Funding

An Introduction to External Investm...

Mark Wyatt, Investment Director, Northern Gritstone

05 June 2024

Intellectual Property

Letting Technology Address the Chal...

Dr Rob Grundy, CEO, Intelligent OMICS

12 June 2024

Views from the Discovery Nation

Tackling the Challenges

Dr Nicola Heron, Chief Strategy Officer, MDC

17 June 2024

Views from the Discovery Nation

Following on from Creating ...

Following on from Creating a Richer National R&D Pipeline with Professor Chris Molloy, in this blog, Tim Newton investigates the trends and challenges that shaped therapeutics financing from 2020 to mid-2023.

By Dr Tim Newton

23 May 2024

Views from the Discovery Nation

UK Life Sciences – The Future is ...

There are signs of recovery, but one that is in its very earliest stages. There is evidence of capital beginning to flow. However, not to all parts of our sector.

By Professor Chris Molloy, CEO at Medicines Discovery Catapult.

22 May 2024